# Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19

> **NCT05158816** · — · COMPLETED · sponsor: **Jessa Hospital** · enrollment: 295 (actual)

## Conditions studied

- COVID-19

## Interventions

- **PROCEDURE:** ECMO

## Key facts

- **NCT ID:** NCT05158816
- **Lead sponsor:** Jessa Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-08
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2022-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05158816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05158816, "Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05158816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*